β-amyloid modulates tyrosine kinase B receptor expression in SHSY5Y neuroblastoma cells: Influence of the antioxidant melatonin

Neuroscience

Volumn 120, Issue 3, 2003, Pages 659-665

  Olivieri, G ^a   Otten, U ^c   Meier, F ^b   Baysang, G ^b   Dimitriades Schmutz, B ^c   Muller Spahn F ^b   Savaskan, E ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Alzheimer's disease; Melatonin; Oxidative stress; SHSY5Y neuroblastoma cells; Trk B; amyloid

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT; BRAIN DERIVED NEUROTROPHIC FACTOR; HYDROGEN PEROXIDE; MELATONIN; MESSENGER RNA; RNA; TYROSINE KINASE B RECEPTOR; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG EXPOSURE; HUMAN; HUMAN CELL; MEASUREMENT; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SECRETION; RNA ANALYSIS; TUMOR CELL CULTURE;

EID: 0041765742     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00342-7     Document Type: Article

References (59)

1. Allegra M., Reiter R.J., Tan D.X., Gentile C., Tesoiere L., Livrea M.A. The chemistry of melatonin's interaction with reactive species. J Pineal Res. 34:2003;1-10.
2. Allen S.J., Wilcock G.K., Dawbarn D. Profound and selective loss of catalytic Trk B immunoreactivity in Alzheimer's disease. Biochem Biophys Res Commun. 264:1991;648-651.
3. Appel S.H. A unifying hypothesis for the cause of amyotrophic lateral sclerosis, Parkinsonism and Alzheimer's disease. Ann Neurol. 10:1981;499-505.
4. Baek J.K., Heaton M.B., Walker D.W. Up-regulation of high-affinity neurotrophin receptor, trk B-like protein on Western blots of rat cortex after chronic ethanol treatment. Brain Res Mol Brain Res. 40:1996;161-164.
5. Baxter G.T., Radeke M.J., Kuo R.C., Makrides V., Hinkle B., Hoang R., Medina-Selby A., Coit D., Valenzuela P., Feinstein S.C. Signal transduction mediated by the truncated trk B receptor isoforms, trk B T1 and trk B T2. J Neurosci. 17:1997;2683-2690.
6. Beck K.D., Lamballe F., Klein R., Barbacid M., Schauwecker P.E., McNeill T.H., Finch C.E., Hefti F., Day J.R. Induction of non-catalytic Trk B neurotrophin receptors during axonal sprouting in the adult hippocampus. J Neurosci. 13:1993;4001-4004.
7. Behl C., Davis J., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β-protein toxicity. Cell. 77:1994;817-827.
8. Behl C. Amyloid beta-peptide toxicity and oxidative stress in Alzheimer's disease. Cell Tissue Res. 290:1997;471-480.
9. Benzi G., Moretti A. Are reactive oxygen species involved in Alzheimer's disease? Neurobiol Aging. 16:1995;661-674.
10. Berkmeier L.R., Winslow J.W., Kaplan D.R., Nikolies K., Goeddel D.V., Rosenthal A. Neurotrophin-5 a novel neurotrophic factor that activates Trk A and Trk B . Neuron. 7:1991;857-866.
11. Bothwell M. Functional interactions of neurotrophins and neurotrophin receptors. Annu Rev Neurosci. 18:1995;223-253.
12. Butterfield D.A., Hensley K., Harris M., Mattson M., Carney J. beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion implications for Alzheimer's disease . Biochem Biophys Res Commun. 200:1994;710-715.
13. Chao M.V., Hempstead B.L. p75 and Trk a two-receptor system . Trends Neurosci. 18:1995;321-326.
14. Connor B., Young D., Lawlor P., Gai W., Waldvogel H., Faull R.L., Dragnow M. Trk receptor alterations in Alzheimer's disease. Brain Res Mol Brain Res. 42:1996;1-17.
15. Croll S.D., Ip N.Y., Lindsay R.M., Wiegand S.J. Expression of BDNF and trkB as a function of age and cognitive performance. Brain Res. 812:1998;200-208.
16. Daniels W.M., van Rensburg S.J., van Zyl J.M., Taljaard J.J. Melatonin prevents beta-amyloid induced lipid peroxidation. J Pineal Res. 24:1998;78-82.
17. Dechant G., Rodriguez-Tebar A., Barde Y. Neurotrophin receptors. Prog Neurobiol. 42:1994;347-352.
18. del Rio L.A., Sandalio L.M., Palma J.M., Bueno P., Corpas F.J. Metabolism of oxygen radicals in peroxisomes and cellular implications. Free Rad Biol Med. 13:1992;557-580.
19. Eide F.F., Vining E.R., Eide B.L., Zang K., Wang X.-Y., Reichardt L.F. Naturally occurring truncated trkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signaling. J Neurosci. 16:1996;3123-3129.
20. Ernfors P., Lindefors N., Chan-Palay V., Persson H. Cholinergic neurons of the nucleus basalis express elevated levels of nerve growth factor receptor mRNA in senile dementia of the Alzheimer type. Dementia. 1:1990;138-145.
21. Ferrer I., Marin C., Rey M.J., Ribalta T., Goutan E., Blanco R., Tolosa E., Mart I.E. BDNF and full-length and truncated TrkB expression in Alzheimer disease implications in therapeutic strategies . J Neuropathol Exp Neurol. 58:1990;729-739.
22. Frisen J., Verge V.M.K., Fried K., Risling M., Persson H., Trotter J., Hokfelt T., Lindholm D. Characterisation of glial trk B receptors differential response to injury in the central and peripheral nervous systems . Proc Natl Acad Sci USA. 90:1993;4971-4975.
23. Gabaizadeh R., Staecker H., Liu W., Van De Water T.R. BDNF protection of auditory neurons from cisplatin involves changes in intracellular levels of both reactive oxygen species and glutathione. Brain Res Mol Brain Res. 50:1997;71-78.
24. Goetz R., Koest R., Winkler C., Raulf F., Lottspeich F., Schartl M., Thoenen H. Neurotrophin-6 is a new member of the nerve growth factor family. Nature. 372:1994;266-269.
25. Gong L., Wyatt R.J., Baker I., Masserano J.M. Brain-derived and glial cell line-derived neurotrophic factors protect a catecholaminergic cell line from dopamine-induced cell death. Neurosci Lett. 263:1999;153-156.
26. Hensley K., Carney J.M., Mattson M.P., Aksenova M., Harris M., Wu J.F., Floyd R.A. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide relevance to Alzheimer's disease . Proc Natl Acad Sci USA. 91:1994;3270-3274.
27. Hock C., Heese K., Müller-Spahn F., Hulette C., Rosenberg C., Otten U. Decreased TrkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease. Neurosci Lett. 241:1998;151-154.
28. Ip N.Y., Yancoupoulos G.D. Neurotrophic factors and their receptors. Ann Neurol. 35:1994;s13-s16.
29. Kaplan D.R., Martin-Zanca D., Parada L.F. Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Nature. 350:1991;158-160.
30. Kaplan D.R., Miller F.D. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol. 10:2000;381-391.
31. Klein R., Conway D., Parada L.F., Barbacid M. The trk B tyrosine protein kinase receptor gene codes for a second neurogenic receptor that lacks the catalytic kinase domain. Cell. 61:1990;647-656.
32. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
33. Lindsay R.M. Neurotrophins and receptors. Prog Brain Res. 103:1994;3-14.
34. Liu F., Ng T.B. Effect of indoles on activities of the antioxidant defense enzymes superoxide dismutase, catalase, and glutathione reductase, and levels of reduced and oxidised glutathione in rat tissues. Biochem Cell Biol. 78:2000;447-453.
35. Lucidi-Phillipi C.A., Gage F.H. The neurotrophin hypothesis and the cholinergic basal forebrain projection. Prog Brain Res. 98:1993;241-249.
36. Maness L.M., Kastin A.J., Webber J.T., Banks W.A., Beckman B.S., Zadina J.E. The neurotrophins and their receptors structure, function and neuropathology . Neurosci Biobehav Rev. 18:1994;143-159.
37. Martin G.M., Austad S.N., Johnson T.E. Genetic analysis of aging role of oxidative and environmental stresses . Nat Genet. 13:1996;25-34.
38. Middlemas D.M., Kihl B.K., Zhou J., Zhu X. Brain-derived neurotrophic factor promotes survival and chemoprotection of human neuroblastoma cells. J Biol Chem. 274:1999;16451-16460.
39. Mufson E.J., Kordower J.H. Cortical neurons express nerve growth factors in advanced age and Alzheimer's disease. Proc Natl Acad Sci USA. 89:1992;569-573.
40. Mufson E.J., Conner J.M., Kordower J.H. Nerve growth factor in Alzheimer's disease defective retrograde transport to nucleus basalis . Neuroreport. 6:1995;1063-1066.
41. Pacifici R.E., Davies K.J.A. Protein, lipid and DNA repair systems in oxidative stress the free-radical theory of aging revisited . Gerontology. 37:1991;166-180.
42. Pappolla M.A., Bozner P., Soto C., Shao H., Robakis N.K., Zagorski M., Frangione B., Ghiso J. Inhibition of Alzheimer beta-fibrillogenesis by melatonin. J Biol Chem. 273:1998;7185-7188.
43. Pappolla M.A., Chyan Y.J., Poeggeler B., Frangione B., Wilson B., Ghiso J., Reiter R.J. An assessment of the antioxidant and antiamyloidogenic properties of melatonin implications for Alzheimer's disease . J Neural Trans. 107:2000;203-231.
44. Phillips H.S., Hains J.M., Armanini M., Laramee G.R., Johnson S.A., Winslow J.W. DNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron. 7:1991;695-702.
45. Reiter R. Oxidative processes and anti-oxidative defence mechanisms in the aging brain. FASEB J. 9:1995;526-533.
46. Romanczyk T.B., Weickert S., Webster M.J., Herman M.M., Akil M., Kleinman J.E. Alterations in trk B mRNA in the human prefrontal cortex throughout the lifespan. Eur J Neurosci. 15:2002;269-280.
47. Rylett R.J., Williams L.R. Role of neurotrophins in cholinergic-neurone function in the adult and aged CNS. Trends Neurosci. 17:1994;486-489.
48. Saitiel A.R., Decker S.J. Cellular mechanisms of signal transduction for neurotrophins. BioEssay. 16:1994;405-411.
49. Savaskan E., Müller-Spahn F., Olivieri G., Bruttel S., Otten U., Rosenberg C., Hulette C., Hock C. Alterations in Trk A, Trk B and Trk C receptor immunoreactivities in parietal cortex and cerebellum in Alzheimer's disease. Eur J Neurol. 44:2000;172-180.
50. Selkoe D.J. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol. 10:1994;373-403.
51. 2 induced lipid peroxidation in homogenates of different rat brain regions. J Pineal Res. 19:1995;51-56.
52. Skaper S.D., Floreani M., Negro A., Facci L., Giusti P. Neurotrophins rescue cerebellar granule neurons from oxidative stress-mediated apoptotic death selective involvement of phosphatidylinositol 3-kinase and the mitogen activated protein kinase pathway . J Neurochem. 70:1998;1859-1868.
53. Snider W.D. Function of the neurotrophins during nervous system development what the knockouts are teaching us . Cell. 77:1994;627-638.
54. Spina M.B., Squinto S.P., Miller J., Lindsay R.M., Hyman C. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity involvement of the glutathione system . J Neurochem. 59:1993;99-106.
55. Tan D.X., Manchester L.C., Hardeland R., Lopez-Burillo S., Mayo J.C., Sainz R.M., Reiter R.J. Melatonin a tissue factor, an autocoid, a paracoid and an antioxidant vitamin . J Pineal Res. 34:2003;75-78.
56. Todoroki S., Yamaguchi M., Cho S., Sumikawa K. Molecular mechanisms involved in the antioxidant effect of melatonin. Anesthesiology. 89:1998;204.
57. Urata Y., Honma S., Goto S., Todonoki S., Jida T., Cho S., Honma K., Rondo T. Melatonin induces γ-glutamylcysteine synthase mediated by activator protein-1 in human vascular epithelium cells. Free Rad Biol Med. 127:1999;838-847.
58. Walter J., Kern-Veits B., Huf J., Stolze B., Bonhoeffer F. Recognition of position-specific properties of tectal cell membranes by retinal axons in vitro. Development. 1101:1987;685-696.
59. Yang K., Mu X.S., Hayes R.L. Increased cortical nuclear factor-kappa-B DNA binding activity after traumatic brain injury in rats. Neurosci Lett. 197:1995;101-104.